Lv71
4610 积分 2021-05-06 加入
Identification of a Novel Indolizine RORγT Inverse Agonist Using the AI-Driven Drug Design Platform
6天前
已完结
Plasma Protein Binding as an Optimizable Parameter for In Vivo Efficacy
13天前
已完结
Optimization of Brain Penetrant SARM1 Orthosteric Inhibitors and Discovery of Their Paradoxical Subinhibitory Activation
13天前
已完结
Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91
20天前
已完结
SAR study on Novel truxillic acid monoester-Based inhibitors of fatty acid binding proteins as Next-Generation antinociceptive agents
25天前
已完结
Fatty acid binding protein 5 inhibitors as novel anticancer agents against metastatic castration-resistant prostate cancer
26天前
已完结
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor
26天前
已完结
Discovery of 2-Amino-7-Amide Quinazoline Derivatives as Potent and Orally Bioavailable Inhibitors Targeting Extracellular Signal-Regulated Kinase 1/2
1个月前
已完结
Rational Design of Dual Degraders by Incorporating Molecular Glue Structural Features into PROTAC Degraders
1个月前
已完结
Discovery of a Potent, Selective, and Brain-Penetrant Checkpoint Kinase 1 Inhibitor, BEN-28010, for the Treatment of Glioblastoma
1个月前
已完结
皖公网安备34019202002308
